JP2024542409A5 - - Google Patents
Info
- Publication number
- JP2024542409A5 JP2024542409A5 JP2024527215A JP2024527215A JP2024542409A5 JP 2024542409 A5 JP2024542409 A5 JP 2024542409A5 JP 2024527215 A JP2024527215 A JP 2024527215A JP 2024527215 A JP2024527215 A JP 2024527215A JP 2024542409 A5 JP2024542409 A5 JP 2024542409A5
- Authority
- JP
- Japan
- Prior art keywords
- trim21
- clec
- antibody
- compound
- binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21306571.7 | 2021-11-09 | ||
| EP21306571 | 2021-11-09 | ||
| PCT/EP2022/081332 WO2023083890A1 (en) | 2021-11-09 | 2022-11-09 | Identification of clec-1 ligand and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024542409A JP2024542409A (ja) | 2024-11-15 |
| JP2024542409A5 true JP2024542409A5 (https=) | 2025-10-28 |
Family
ID=78821542
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024527215A Pending JP2024542409A (ja) | 2021-11-09 | 2022-11-09 | Ｃｌｅｃ－１リガンドの同定及びその使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250026839A1 (https=) |
| EP (1) | EP4429692A1 (https=) |
| JP (1) | JP2024542409A (https=) |
| CN (1) | CN118510534A (https=) |
| WO (1) | WO2023083890A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025032213A1 (en) * | 2023-08-10 | 2025-02-13 | Ose Immunotherapeutics | Identification of hla-dra as a ligand of clec-1 and uses thereof |
| WO2025080670A1 (en) * | 2023-10-09 | 2025-04-17 | The Johns Hopkins University | Ro52 targeting antibody or antigen binding fragments thereof for use in treating cancer |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1621554T4 (da) | 1992-08-21 | 2012-12-17 | Univ Bruxelles | Immunoglobuliner blottet for lette kæder |
| EP0739981A1 (en) | 1995-04-25 | 1996-10-30 | Vrije Universiteit Brussel | Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes |
| US20140220007A1 (en) * | 2013-02-01 | 2014-08-07 | Meso Scale Technologies, Llc | Lupus biomarkers |
| SI3529262T1 (sl) | 2016-10-21 | 2021-12-31 | Inserm - Institut National De La Sante Et De La Recherche Medicale | Postopki za spodbujanje odgovora T-celic |
| EP4069372A1 (en) * | 2019-12-05 | 2022-10-12 | Ose Immunotherapeutics | Anti-clec-1a antibodies and antigen-binding fragment thereof |
-
2022
- 2022-11-09 CN CN202280088185.9A patent/CN118510534A/zh active Pending
- 2022-11-09 US US18/707,922 patent/US20250026839A1/en active Pending
- 2022-11-09 WO PCT/EP2022/081332 patent/WO2023083890A1/en not_active Ceased
- 2022-11-09 JP JP2024527215A patent/JP2024542409A/ja active Pending
- 2022-11-09 EP EP22817171.6A patent/EP4429692A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7375122B2 (ja) | ヒト化、マウスまたはキメラ抗ｃｄ４７モノクローナル抗体 | |
| CN110461872B (zh) | Cd47抗原结合单元及其用途 | |
| US11440972B2 (en) | Bispecific antibodies and uses thereof | |
| JP2021510535A (ja) | Ｈｅｒ３抗原結合性分子 | |
| US20240002539A1 (en) | Multispecific antibodies and uses thereof | |
| KR102107963B1 (ko) | 탄산탈수소 효소에 결합하는 항체 및 이의 용도 | |
| JP2024542409A5 (https=) | ||
| JP2025510642A5 (https=) | ||
| KR20240155337A (ko) | 항-pd-l2 항체 | |
| US20220169728A1 (en) | Bispecific antibodies and uses thereof | |
| WO2024088346A1 (en) | Anti-ccr8 antibodies and uses thereof | |
| JP7557457B2 (ja) | 抗ヒトｐｄ－ｌ１抗体とその使用 | |
| GB2524553A (en) | Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and use thereof for treating cancer cachexia | |
| US20230242640A1 (en) | ANTI-SIRPg Compounds | |
| TWI917473B (zh) | Bcma/taci抗原結合分子 | |
| WO2022037672A1 (en) | Anti-cd47 antibodies and uses thereof | |
| KR20260062948A (ko) | Ctla4/tigit 결합 단백질 및 이의 의학적 용도 | |
| KR20230144965A (ko) | Her2 저발현 암의 치료 또는 예방용 약학적 조성물 | |
| WO2026010986A1 (en) | 5t4-binding proteins | |
| HK40120638A (zh) | 抗ccr8抗体及其用途 | |
| HK40113710A (zh) | 用於治疗或预防her2低表达水平的癌症的药物组合物 | |
| WO2022238459A1 (en) | New humanized anti-vegfc antibodies and uses thereof | |
| HK40064279A (en) | Bispecific antibodies and uses thereof | |
| HK40033364A (en) | Bispecific antibodies and uses thereof |